Evaluation of the therapeutic efficacy of high-intensity focused ultrasound ablation combined with different drugs in the treatment of adenomyosis

Objectives To observe the therapeutic efficacy of high-intensity focused ultrasound (HIFU) combined with different pharmacological treatments for adenomyosis.Materials and methods A total of 126 patients with adenomyosis who underwent HIFU combined with pharmacological treatment were retrospectively...

Full description

Saved in:
Bibliographic Details
Main Authors: Yu Dai, Ling Liu, Guiyuan Yu, Yan Peng, Na Chen, Jiahong Gao, Qiuling Shi, Ping Jin
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:International Journal of Hyperthermia
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/02656736.2024.2384471
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841560920412651520
author Yu Dai
Ling Liu
Guiyuan Yu
Yan Peng
Na Chen
Jiahong Gao
Qiuling Shi
Ping Jin
author_facet Yu Dai
Ling Liu
Guiyuan Yu
Yan Peng
Na Chen
Jiahong Gao
Qiuling Shi
Ping Jin
author_sort Yu Dai
collection DOAJ
description Objectives To observe the therapeutic efficacy of high-intensity focused ultrasound (HIFU) combined with different pharmacological treatments for adenomyosis.Materials and methods A total of 126 patients with adenomyosis who underwent HIFU combined with pharmacological treatment were retrospectively reviewed. Patients were treated with either dienogest (DNG) (Group A, N = 38) or GnRH-a (Group B, N = 88) for three months after HIFU, and received levonorgestrel-releasing intrauterine systems (LNG-IUS) at the end of the third month. Visual Analog Scale (VAS) and Pictorial Blood Loss Assessment Chart (PBAC) scores were used for evaluating symptom improvement.Results After propensity score matching (1:2), 38 patients were included in Group A and 76 in Group B. All patients showed significant improvement in VAS and PBAC scores after HIFU, but the PBAC score of Group A was significantly higher than that of patients in Group B at 18 months [11.50 (1.00, 29.50) vs. 0.00 (0.00, 16.50), p < 0.01] and 24 months [4.00 (0.25, 27.75) vs. 0.00 (0.00, 12.75), p = 0.04] after HIFU. Furthermore, patients in Group B had a greater uterine volume reduction at 24 months after HIFU than that of patients in Group A [51.00 (27.00, 62.00) vs. 30.00 (17.00, 42.75, p = 0.02)]. However, the adverse effects in Group A were lower than those in Group B [7 (15.79) vs. 35 (46.05), p < 0.01]. No significant difference was observed in the recurrence rate between the two groups.Conclusions HIFU combined with DNG and LNG-IUS is a safe and effective treatment for patients with adenomyosis.
format Article
id doaj-art-c0f0dfcb9a3841b0b9d2acd020a9600b
institution Kabale University
issn 0265-6736
1464-5157
language English
publishDate 2024-12-01
publisher Taylor & Francis Group
record_format Article
series International Journal of Hyperthermia
spelling doaj-art-c0f0dfcb9a3841b0b9d2acd020a9600b2025-01-03T09:30:27ZengTaylor & Francis GroupInternational Journal of Hyperthermia0265-67361464-51572024-12-0141110.1080/02656736.2024.2384471Evaluation of the therapeutic efficacy of high-intensity focused ultrasound ablation combined with different drugs in the treatment of adenomyosisYu Dai0Ling Liu1Guiyuan Yu2Yan Peng3Na Chen4Jiahong Gao5Qiuling Shi6Ping Jin7Shenzhen Maternity and Child Healthcare Hospital, Shenzhen, ChinaShenzhen Maternity and Child Healthcare Hospital, Shenzhen, ChinaShenzhen Maternity and Child Healthcare Hospital, Shenzhen, ChinaShenzhen Maternity and Child Healthcare Hospital, Shenzhen, ChinaShenzhen Maternity and Child Healthcare Hospital, Shenzhen, ChinaShenzhen Maternity and Child Healthcare Hospital, Shenzhen, ChinaState Key Laboratory of Ultrasound in Medicine and Engineering, Chongqing Medical University, Chongqing, ChinaShenzhen Maternity and Child Healthcare Hospital, Shenzhen, ChinaObjectives To observe the therapeutic efficacy of high-intensity focused ultrasound (HIFU) combined with different pharmacological treatments for adenomyosis.Materials and methods A total of 126 patients with adenomyosis who underwent HIFU combined with pharmacological treatment were retrospectively reviewed. Patients were treated with either dienogest (DNG) (Group A, N = 38) or GnRH-a (Group B, N = 88) for three months after HIFU, and received levonorgestrel-releasing intrauterine systems (LNG-IUS) at the end of the third month. Visual Analog Scale (VAS) and Pictorial Blood Loss Assessment Chart (PBAC) scores were used for evaluating symptom improvement.Results After propensity score matching (1:2), 38 patients were included in Group A and 76 in Group B. All patients showed significant improvement in VAS and PBAC scores after HIFU, but the PBAC score of Group A was significantly higher than that of patients in Group B at 18 months [11.50 (1.00, 29.50) vs. 0.00 (0.00, 16.50), p < 0.01] and 24 months [4.00 (0.25, 27.75) vs. 0.00 (0.00, 12.75), p = 0.04] after HIFU. Furthermore, patients in Group B had a greater uterine volume reduction at 24 months after HIFU than that of patients in Group A [51.00 (27.00, 62.00) vs. 30.00 (17.00, 42.75, p = 0.02)]. However, the adverse effects in Group A were lower than those in Group B [7 (15.79) vs. 35 (46.05), p < 0.01]. No significant difference was observed in the recurrence rate between the two groups.Conclusions HIFU combined with DNG and LNG-IUS is a safe and effective treatment for patients with adenomyosis.https://www.tandfonline.com/doi/10.1080/02656736.2024.2384471Adenomyosishigh-intensity focused ultrasounddienogestGnRH-aLNG-IUS
spellingShingle Yu Dai
Ling Liu
Guiyuan Yu
Yan Peng
Na Chen
Jiahong Gao
Qiuling Shi
Ping Jin
Evaluation of the therapeutic efficacy of high-intensity focused ultrasound ablation combined with different drugs in the treatment of adenomyosis
International Journal of Hyperthermia
Adenomyosis
high-intensity focused ultrasound
dienogest
GnRH-a
LNG-IUS
title Evaluation of the therapeutic efficacy of high-intensity focused ultrasound ablation combined with different drugs in the treatment of adenomyosis
title_full Evaluation of the therapeutic efficacy of high-intensity focused ultrasound ablation combined with different drugs in the treatment of adenomyosis
title_fullStr Evaluation of the therapeutic efficacy of high-intensity focused ultrasound ablation combined with different drugs in the treatment of adenomyosis
title_full_unstemmed Evaluation of the therapeutic efficacy of high-intensity focused ultrasound ablation combined with different drugs in the treatment of adenomyosis
title_short Evaluation of the therapeutic efficacy of high-intensity focused ultrasound ablation combined with different drugs in the treatment of adenomyosis
title_sort evaluation of the therapeutic efficacy of high intensity focused ultrasound ablation combined with different drugs in the treatment of adenomyosis
topic Adenomyosis
high-intensity focused ultrasound
dienogest
GnRH-a
LNG-IUS
url https://www.tandfonline.com/doi/10.1080/02656736.2024.2384471
work_keys_str_mv AT yudai evaluationofthetherapeuticefficacyofhighintensityfocusedultrasoundablationcombinedwithdifferentdrugsinthetreatmentofadenomyosis
AT lingliu evaluationofthetherapeuticefficacyofhighintensityfocusedultrasoundablationcombinedwithdifferentdrugsinthetreatmentofadenomyosis
AT guiyuanyu evaluationofthetherapeuticefficacyofhighintensityfocusedultrasoundablationcombinedwithdifferentdrugsinthetreatmentofadenomyosis
AT yanpeng evaluationofthetherapeuticefficacyofhighintensityfocusedultrasoundablationcombinedwithdifferentdrugsinthetreatmentofadenomyosis
AT nachen evaluationofthetherapeuticefficacyofhighintensityfocusedultrasoundablationcombinedwithdifferentdrugsinthetreatmentofadenomyosis
AT jiahonggao evaluationofthetherapeuticefficacyofhighintensityfocusedultrasoundablationcombinedwithdifferentdrugsinthetreatmentofadenomyosis
AT qiulingshi evaluationofthetherapeuticefficacyofhighintensityfocusedultrasoundablationcombinedwithdifferentdrugsinthetreatmentofadenomyosis
AT pingjin evaluationofthetherapeuticefficacyofhighintensityfocusedultrasoundablationcombinedwithdifferentdrugsinthetreatmentofadenomyosis